Antidepressant medications and risk for cancer

Epidemiology

Volumn 11, Issue 2, 2000, Pages 171-176

  Dalton, Susanne Oksbjerg ^a   Johansen, Christoffer ^a   Mellemkjær, Lene ^a   Sørensen, Henrik Toft ^b   McLaughlin, Joseph K ^a   Olsen, Jørn ^b   Olsen, Jørgen H ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

^b NONE

Author keywords

Antidepressant medication; Cancer incidence; Cohort studies; Gender; Monoamine oxidase inhibitors; Pharmacoepidemiology; Serotonin reuptake inhibitors; Tetracyclic antidepressants; Tricyclic antidepressants

Indexed keywords

ANTIDEPRESSANT AGENT; MONOAMINE OXIDASE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NONHODGKIN LYMPHOMA; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; COHORT STUDIES; DENMARK; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INCIDENCE; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; NEOPLASMS; PHARMACOEPIDEMIOLOGY; POISSON DISTRIBUTION; REGISTRIES; RISK FACTORS; SMOKING;

EID: 0034005121     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200003000-00015     Document Type: Article

References (33)

1. Finley PR. Selective serotonin re-uptake inhibitors: pharmacologic profiles and potential therapeutic distinctions. Ann Pharmacother 1994;28:1359-1369.
2. LaBella FS, Brandes LJ. Enhancement of tumour growth by drugs with some common molecular actions. Mol Carcinog 1996;16:68-76.
3. Eisen JN, Irwin J, Quay J, Livnat S. The effect of antidepressants on immune function in mice. Biol Psychiatry 1989;26:805-817.
4. Brandes LJ, Arron RJ, Bogdanovic P, Tong J, Zaborniak CLF, Hogg GR, Warrington RC, Fang W, LaBella FS. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992;52:3796-3800.
5. Iishi H, Tatsuta M, Baba M, Taniguchi H. Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis 1993;14:1837-1840.
6. Hilakivi-Clarke L, Clarke R, Lippman ME. Perinatal factors increase breast cancer risk. Breast Cancer Res Treat 1994;31:273-284.
7. Friedman GD. An editor's comment. Am J Epidemiol 1992;136:1415-1416.
8. Harlow BL, Cramer DW. Self-reported use of antidepressants or benzodiazepine tranquilizers and risk of epithelial ovarian cancer: evidence from two combined case-control studies (Massachusetts, United States). Cancer Causes Control 1995;6:130-134.
9. Harlow BL, Cramer DW, Baron JA, Titus-Ernstoff L, Greenberg ER. Psychotropic medication use and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 1998;7:697-702.
10. Wallace RB, Sherman BM, Bean JA. A case-control study of breast cancer and psychotropic drug use. Oncology 1982;39:279-283.
11. Rosholm J-U, Gram LF, Isacsson G, Hallas J, Bergman U. Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study. Eur J Clin Pharmacol 1997;52:205-209.
12. Ohayon MM, Caulet M, Priest RG, Guilleminault C. Psychotropic medication consumption patterns in the UK general population. J Clin Epidemiol 1998;51:273-283.
13. Nielsen GL, Sørensen HT, Zhou W, Steffensen FH, Olsen J. The Pharmacoepidemiologic Prescription Database of North Jutland: a valid tool in pharmacoepidemiological research. Int J Risk Saf Med 1997;10:203-205.
14. Capellá D. Descriptive tools and analysis. In: Dukes MNG, ed. Drug Utilization Studies: Methods and Uses. WHO Regional Publications (European Series No. 45). Geneva; World Health Organization, 1993;55-78.
15. Sørengen HT, Larsen BO. A population-based Danish data resource with possible high validity in pharmacoepidemiological research. J Med Syst 1994;18:33-38.
16. Dupont A. A national psychiatric case register as a tool for mental health planning, research, and administration: the Danish model. In: Laska EM, Gulbinat WH, Regier DA, eds. Information Support to Mental Health Programs: An International Perspective. New York: Human Sciences Press, 1983;257-274.
17. Jensen OM, Storm HH, Jensen HS. Cancer registration in Denmark and the study of multiple cancer, 1943-1980. Natl Cancer Inst Monogr 1985;68: 245-251.
18. Storm HH, Pihl J, Michelsen E. Cancer incidence in Denmark, 1993. Copenhagen: Danish Cancer Society, 1996.
19. Storm, HH., Michelsen EV, Clemmensen IH, Pihl J. The Danish Cancer Registry: history, content, quality and use. Dan Med Bull 1997;44:535-539.
20. Rothman KJ, Boice JD Jr. Epidemiological analysis with a programmable calculator. U.S. Department of Health and Human Services Pub. No. (NIH)79-1649. Washington DC: U.S. Government Printing Office, 1979.
21. Goodwin FK, Redfield Jamison K. Manic-Depressive Illness. New York: Oxford University Press, 1990.
22. Dreyer L, Pukkala JF, Andersen A. Tobacco smoking. Acta Pathol Microbiol Immunol Scand 1997;105(suppl 76):9-47.
23. Danmarks Statistik. Statistics Denmark. Statistical Ten-Year Review 1996 (in Danish). Copenhagen: Danmarks Statistik, 1996.
24. Matthews J. Concern over Prozac-induced tumour growth may dwindle following FDA study. J Natl Cancer Inst 1995;87:1285-1287.
25. Bendele RA, Adams ER, Hoffman WP, Gries CL, Morton DM. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Cancer Res 1992;52:6931-6935.
26. Sauter C. Cytostatic activity of commonly used tricyclic antidepressants. Oncology 1989;46:155-157.
27. Tutton PJM, Barkla DH. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 1982;46:260-265.
28. Kinlen LJ. Immunosuppressive therapy and acquired immunological disorders. Cancer Res 1992;52:5474-5476.
29. Miller AH, Spencer RL, McEwen BS, Srein M. Depression, adrenal steroids and the immune system. Ann Med 1993;25:481-487.
30. Cover H, Irwin M. Immunity and depression: insomnia, retardation and reduction of natural killer cell activity. J Behav Med 1994;17:217-223.
31. McGee R, Williams S, Elwood M. Depression and the development of cancer: a meta-analysis. Soc Sci Med 1994;38:187-192.
32. Glassman AH, Heizer JE, Covey LS, Cottler LB, Stetner F, Tipp JE, Johnson J. Smoking, smoking cessation, and major depression. JAMA 1990;264: 1546-1549.
33. Hughes JR, Hatsukami DK, Mitchell JE, Dahlgren LA. Prevalence of smoking among psychiatric outpatients. Am J Psychiatry 1986;143:993-997.